Multiple sclerosis is an in¯ammatory, demyelinating disease of the CNS. Whereas oligodendrocytes have been considered the primary neural cell type most affected, recent evidence indicates that axonal and neuronal degeneration also occurs in both multiple sclerosis and experimental autoimmune encephalomyelitis (EAE), an animal model reproducing many features of multiple sclerosis. The molecular mechanisms underlying neuronal de®cits in multiple sclerosis and EAE remain elusive. To address this issue, we have analysed the expression of genes encoding proteins that play critical roles in ion homeostasis, exocytosis, mitochondrial function and impulse conduction in the Lewis rat lumbar spinal cord during the clinical course of acute EAE. Transcript and protein levels of plasma membrane Ca 2+ ATPase 2 (PMCA2), an essential ion pump expressed exclusively in grey matter and involved in Ca 2+ extrusion, synapsin IIa and syntaxin 1B, important regulators of vesicular exocytosis, were dramatically decreased coincident with the onset of clinical symptoms. In contrast, changes in the expression of several other ion pumps, vesicular proteins, mitochondrial enzymes and sodium channels occurred at more advanced disease stages. Moreover, exposure of spinal cord slice cultures to kainic acid signi®cantly reduced PMCA2 mRNA levels. Taken together, our ®ndings suggest that glutamate, which recently has been implicated in EAE pathogenesis, suppresses neuronal PMCA2 expression leading to Ca 2+ dyshomeostasis at initial clinical phases. Consequently, perturbations in Ca 2+ balance and neurotransmitter exocytosis may partially underlie aberrant neuronal function and communication at onset of symptoms. Altered mitochondrial function and impulse conduction may exacerbate neurological de®cits at subsequent disease stages.
Introduction
Multiple sclerosis is a CNS disease leading to progressive neurological de®cits and permanent disability (Steinman, 1996; Prineas and McDonald, 1997; Antel, 1999; Hickey, 1999) . Experimental autoimmune encephalomyelitis (EAE), the animal model of multiple sclerosis, is induced by immunization of rodents with immunogenic myelin components or by adoptive transfer with T cells reactive against CNS myelin antigens (Wekerle et al., 1994; Steinman, 1999; van der Goes and Dijkstra, 2001) . The clinical symptoms and histopathology of EAE may be diverse depending on the antigen and the animal strain employed. It has been hypothesized that distinct EAE models reproduce different features of multiple sclerosis, a complex disease with variable clinical course (Wekerle et al., 1994) . Immunization of adult Lewis rats with myelin basic protein results in acute, monophasic EAE manifested by progressive ascending weakness leading to hindlimb paralysis and quadriplegia.
Classically, demyelination of structurally intact axons and the resulting impairment in saltatory nerve conduction have been considered as the causes of functional de®cits in multiple sclerosis and EAE (McFarlin and McFarland, 1982a, b; Raine, 1997) . However, the lack of correlation between myelin loss and symptom severity suggests that EAE and multiple sclerosis are more complex than initially believed (Rivera-Quinones et al., 1998; Antel, 1999) . Indeed, studies reporting axonal dysfunction and damage (Ferguson et al., 1997; Trapp et al., 1998 Trapp et al., , 1999 De Stefano et al., 1999; Bitsch et al., 2000; Bjartmar and Trapp, 2001; Bjartmar et al., 2001) , neuronal loss or apoptosis (Smith et al., 2000; Peterson et al., 2001) indicate that multiple sclerosis and EAE are not only demyelinating diseases but neuronal disorders as well (Waxman, 2000a, b; Filippi, 2001) .
The triggers that cause aberrant neuronal axonal function and destruction of myelin are not well de®ned. A correlation between in¯ammatory reaction and axonal injury has been observed (Ferguson et al., 1997; Trapp et al., 1998) . Activated resident microglia and macrophages have also been implicated in myelin and oligodendrocyte damage (for a review see Sriram and Rodriguez, 1997) . Recent studies indicate that glutamate excitotoxicity may be a factor contributing to axonal, neuronal and oligodendrocyte injury during EAE (Pitt et al., 2000; Smith et al., 2000) . Moreover, it has been suggested that increased calcium in¯ux through voltage-dependent calcium channels induces axonal degeneration and neuronal injury (Kornek et al., 2000 (Kornek et al., , 2001 . Calcium dyshomeostasis, which has been implicated in many pathological conditions, may also result from the abnormal function of pumps that extrude Ca 2+ from cells. This possibility has not been investigated in EAE or multiple sclerosis.
In summary, in contrast to the well-de®ned histopathology, the molecular events underlying neuronal impairment contributing to neurological de®cits and persistent disability in EAE and multiple sclerosis remain elusive. To delineate molecular mechanisms responsible for the onset and progression of symptoms in EAE, we de®ned the expression pattern of genes encoding proteins that play essential roles in neuronal function during the clinical course of the disease. Our ®ndings suggest that abnormal Ca 2+ extrusion and vesicular exocytosis may initiate neuronal dysfunction. At later clinical stages, changes in the expression of other genes that encode proteins involved in mitochondrial function and impulse conduction may contribute further to disease progression.
Material and methods

Induction of EAE
Female adult Lewis rats (200±250 g body weight) were immunized in hindlimb footpads with 100 mg of guinea pig myelin basic protein (Sigma, St Louis, MO, USA, or generously provided by Dr A. Ben-Nun) in 50 ml of saline emulsi®ed in 50 ml complete Freund's adjuvant (Difco, Detroit, MI, USA). Control rats received only saline/ adjuvant. Animals were monitored daily for clinical symptoms. A very stereotyped clinical onset and disease course was observed. Neurological impairment was scored as: 0, no neurological symptoms; 1, limp tail [stage E1, observed on day 10 post-injection (PI)]; 2, hindlimb weakness (stage E2, day 11 PI); 3, hindlimb paralysis (stage E3, day 12±13 PI); 4, quadriplegia (stage E4; day 14±15 PI); 5, moribund (past day 16 PI). During the observation period, rats were given food and water ad libitum. Some animals were sacri®ced by exposure to CO 2 /O 2 . Others were anaesthetized with a mixture of ketamine/xylazine and perfused with saline followed by 4% paraformaldehyde in 0.1 M phosphate buffer pH 7.5. Lumbar spinal cords were dissected out and frozen immediately on dry ice. The tissue was kept at ±80°C until further use. All animal procedures were performed according to IACUC and institutional guidelines.
Isolation of RNA
Total RNA was isolated from 100±150 mg of tissue obtained by pooling 2±3 lumbar spinal cords. The Trizol One Step Isolation method was utilized according to the manufacturer's instructions (Life Technologies, Grand Island, NY, USA). All RNA samples were treated with DNase I to remove any trace of contaminating genomic DNA and repuri®ed by phenol/ chloroform extraction. RNA was quanti®ed by measurement of optical density. Samples were stored at ±20°C in the presence of RNase inhibitor.
cDNA microarray analysis
This was performed utilizing the Atlas Rat 1.2 microarrays according to the manufacturer's instructions (Clontech, Palo Alto, CA, USA). The microarray includes 1176 rat cDNAs immobilized on nylon membranes, nine housekeeping cDNAs and negative controls. The list of the cDNAs can be found at the Clontech web site (http://www.clontech.com/ atlas/genelists/7854-1_Ra12.txt). Total RNA was puri®ed from lumbar spinal cords of control and EAE rats (three rats per group; EAE clinical score 3, E3). A 25 mg aliquot of pooled RNA was reverse transcribed in the presence of MMLV reverse transcriptase, gene-speci®c primer mix, 0.5 mM each of dCTP, dGTP and dTTP, and 35 mCi of [a-33 P]dATP (2500 Ci/mmol; Amersham, Piscataway, NJ, USA) in a 30 ml reaction volume at 50°C for 25 min using the Atlas pure total RNA labelling system (Clontech). The arrays were pre-hybridized in Express Hyb hybridization buffer (Atlas hybridization kit) containing heat-denatured salmon testes DNA (Sigma) for 30 min at 68°C. Subsequently, the probe mixture (2±10 Q 10 6 c.p.m.) and 5 ml of human Cot-1DNA were added to the pre-hybridization buffer. Hybridization was performed overnight at 68°C. The arrays were then washed four times in 2Q SSC (standard saline citrate), 1% SDS, and once in 0.1Q SSC, 0.5% SDS for 30 min, each wash at 68°C, and exposed to phosphorimager screens for 5 days. A Storm phosphorimager (Molecular Dynamics, Sunnyvale, CA, USA) and ImageQuant software were used to scan images. Gene expression was custom analysed using Atlas Image 2.0 software by Clontech. The intensity of each spot, quanti®ed after background correction, re¯ected the level of expression of each gene. Experimental variation in the overall intensity of the signal was corrected by normalization of the gene signal with respect to the housekeeping genes in the same array. For each gene, a ratio was generated by dividing the intensity of the spot by the average of the sum of housekeeping genes. Only those housekeeping genes with signal intensity below saturation were considered for normalization. Reproducibility of this technique (80% concordance of signals) was veri®ed by hybridizing probe mixtures generated from two aliquots of the same RNA source to identical arrays. The signal levels of genes selected for further analysis in our study were 30-to 40-fold over the background. In addition, there was at least a 2-fold difference in the expression of the selected genes in EAE versus control (Table 1) .
RT±PCR
This was performed utilizing the Retroscript reverse transcription kit and SuperTaq Polymerase (Ambion, Austin, TX, USA) according to the manufacturer's instructions. A 1±2 mg aliquot of DNase-treated total RNA was reverse transcribed in a total volume of 20 ml. A 2±5 ml aliquot of RT mix was then used for PCR, which was performed in a total volume of 50 ml by denaturation at 94°C for 30 s, annealing at 55°C for 45 s and polymerization at 68°C for 1 min. PCR was completed by 10 min extension at 72°C. PCRs were performed for 30±35 cycles, within the linear range. Products were separated on a 1.5% agarose gel containing ethidium bromide (0.5 mg/ml) and the image was captured using an Alpha digital imaging system. The optical density in each band was then quanti®ed utilizing the Un-Scan-It software (Silk Scienti®c, Orem, UT, USA). Some PCR products were analysed further by sequencing.
Preparation of riboprobes for in situ hybridization
RT±PCR products generated by use of speci®c primers for PMCA2 or a-tubulin were cloned into pCR II-TOPO vector containing SP6 and T7 promoters (Invitrogen, Carlsbad, CA, USA) and sequenced for further con®rmation. Antisense and sense riboprobes were generated using the Digoxigenin (DIG) RNA Labelling Kit according to the manufacturer's instructions (Boehringer Mannheim, Indianapolis, IN, USA). A 1 mg aliquot of linearized plasmid was transcribed at 37°C for 2 h in the presence of 1 mM ATP, CTP and GTP, 0.65 mM UTP, 0.35 mM DIG-UTP, 20 U of RNasin, 40 U of SP6 or T7 RNA polymerase in 40 mM Tris buffer pH 8.0, 10 mM NaCl, 10 mM dithiothreitol and 6 mM MgCl 2 . The DNA template was removed by treatment with DNase I and the probe was precipitated with LiCl and ethanol. The concentration of DIG-labelled riboprobe was determined by utilizing DIG quanti®cation test strips according to the manufacturer's instructions (Boehringer Mannheim). cDNA microarray analysis identi®ed differentially expressed genes in the spinal cord during EAE, including those listed above which showed robust changes in transcript levels (at least 2-fold difference between EAE and control) and which were highly expressed (at least 30-to 40-fold over background). The genes are classi®ed according to their best characterized function. The results obtained with all the listed genes were corroborated subsequently by RT±PCR in 2±3 independent experiments. The ratio of spot intensity re¯ects the relative transcript levels in EAE over control.
In situ hybridization
Controls and EAE (E3) rats (six animals/group) were sacri®ced by cardiac perfusion of saline followed by 4% paraformaldehyde in 0.1 M phosphate buffer pH 7.5. Lumbar spinal cords were dissected out, post-®xed in phosphate buffer for 4 h, cryoprotected in 10 and 15% sucrose and cryosectioned at 10 mm. Sections obtained from control and EAE lumbar spinal cords were mounted on the same slides to minimize experimental variations, ®xed in 4% paraformaldehyde/phosphate buffer for 15 min at room temperature, and treated with 6% H 2 O 2 in phosphate-buffered saline (PBS) containing 0.1% Tween (PBST). Sections were then digested with proteinase K (1 mg/ml) for 15 min at 37°C, followed by incubations in glycine (2 mg/ml, 10 min) and 4% paraformaldehyde/0.2% gluteraldehyde/PBST for 15 min. Prehybridization was performed in buffer containing 50% deionized formamide, 5Q SSC pH 4.5, 1% SDS, 50 mg/ml yeast tRNA and 50 mg/ml heparin at 65°C for 1 h. Hybridization was performed overnight at 65°C in the same buffer containing 1 mg/ml DIG-labelled sense or antisense probe. The sections were then washed in 5Q SSC/50% formamide/1% SDS at 70°C, followed by 4Q SSC/50% formamide at 65°C, blocked in 10% heat-inactivated goat serum/PBS for 1 h at room temperature and incubated in antiDIG±alkaline phosphatase-conjugated antibody (1 : 1000) in PBS at 4°C overnight. Endogenous alkaline phosphatase activity was blocked by pre-treatment with 10 mM levamisole. The colour reaction was developed overnight in the presence of 250 mg/ml NBT (4-nitro blue tetrazolium chloride) and 130 mg/ml BCIP (5-bromo-4-chloro-3-indolylphosphate) as substrate.
Immunocytochemistry
Lumbar spinal cord sections, prepared as described above, were ®rst treated with 10% goat serum/0.1% Triton X-100/ PBS for 1 h at room temperature. They were then incubated in ED-1 (1 : 500; Serotec, Oxford, UK)/0.1% Triton X-100/PBS overnight at 4°C. The rest of the procedure was performed at room temperature. The sections were washed in PBS, incubated in anti-mouse IgG [1/500 (v/v)] followed by avidin±biotin complex (Vectastain ABC kit, Vector Laboratories, Burlingame, CA, USA). Immunopositive cells were visualized by 3,3¢¢-diaminobenzidine reaction product.
Western blot analysis
Lumbar spinal cords of controls or EAE (E1±E3) rats (three animals/group) were homogenized on ice with a motorized pestle in 1 ml of buffer A (10 mM HEPES pH 7.0, 10% sucrose, 0.4 mM phenylmethylsulfonyl¯uoride, 5 mM EDTA, 2 mg/ml leupeptin, 2 mg/ml aprotinin, 2 mg/ml pepstatin). The homogenate was then passed ®ve times through a syringe with a 22-gauge needle and centrifuged at 800 g for 5 min. 
Spinal cord slice cultures
Adult rats were sacri®ced by exposure to CO 2 /O 2 . Lumbar spinal cords were excised, sliced into 1 mm sections and immediately placed in 1 ml of de®ned medium consisting of L-15: neurobasal medium (2 : 1; Gibco/BRL, Rockville, MD, USA) containing insulin (5 mg/ml), transferrin (100 mg/ml), selenium (40 ng/ml), putrescine (16 ng/ml), progesterone (60 ng/ml) and 1 U of penicillin/streptomycin. Kainic acid was then introduced at the concentrations indicated in the Results. Controls were maintained in medium containing vehicle. The slices were incubated for 6 h at 37°C. At the end of the incubation period, the slices were homogenized in Trizol reagent and RNA was prepared as described above. Some slices were ®xed in 4% paraformaldehyde, cryoprotected in 10 and 20% sucrose and frozen on dry ice. Cryostat sections (10 mm) were mounted on poly-L-lysine-coated slides and utilized for assessment of DNA fragmentation by TUNEL assay, a hallmark of cell death. TUNEL assay was performed utilizing the ApopTag kit (Intergen, Purchase, NY, USA) according to the manufacturer's instructions. Eight control and eight kainic acidtreated slices were analysed. At least ®ve sections from each slice were used for TUNEL assay. Control and experimental samples were mounted on the same slide, side by side. The experiment was repeated twice and yielded similar results.
Results
To identify differentially expressed genes in the EAE lumbar spinal cord, we ®rst performed cDNA microarray analysis at disease stage E3. We selected a number of differentially expressed genes for further studies because they are expressed exclusively or mainly by neurons, they play critical roles in important cellular functions including ion homeostasis, neurotransmitter exocytosis, energy metabolism or impulse conduction, and their transcript level was altered greatly. The genes were classi®ed according to the best characterized function of the protein which they encode (Table 1) . Thus, cDNA microarray pro®ling provided an initial and global insight into potential cellular mechanisms that may be affected during a de®ned stage of the disease. We further corroborated these ®ndings by semi-quantitative RT± PCR utilizing the same source of RNA as that employed for cDNA microarray analysis (stage E3). Subsequently, we further validated our ®ndings by performing at least 2±3 additional, independent experiments employing distinct groups of rats (2±3 rats/group) during the course of the disease (stages E1±E3), as reported below.
PMCA2 mRNA and protein levels are decreased at onset of symptoms One of our observations by cDNA microarray analysis was a pronounced change in the expression of several pumps which modulate ion, and in particular Ca 2+ , homeostasis including plasma membrane Ca 2+ ATPase 2 (PMCA2), sarcoplasmic and endoplasmic reticulum Ca 2+ -activated ATPase 2 (SERCA2) and Na + /K + transporting ATPase b2 subunit (Table 1) . As Ca 2+ balance plays a pivotal role in the function and survival of cells, including neurons, we further analysed these genes and corroborated our microarray ®ndings by semi-quantitative RT±PCR utilizing speci®c primers for each pump (Table 2) . We examined the expression of the aforementioned ion pumps during the course of the disease starting at E1 (tail weakness only; clinical score 1) in order to determine the clinical stage when the ®rst signi®cant changes in expression occur. Transcript levels of PMCA2, a major pump mediating Ca 2+ extrusion from cells (Carafoli, 1987; Miller, 1991; Garcia and Strehler, 1999) , were signi®cantly decreased at E1 [ Fig. 1 , 88% decrease, P < 0.001 by analysis of variance (ANOVA); Scheffe's post hoc test] and consistently remained low until E3, the latest clinical stage examined. Transcript levels of SERCA2, which mediates the sequestration of intracellular Ca 2+ into the endoplasmic reticulum, and Na + /K + transporting ATPase b2 subunit, which regulates Na + homeostasis, were not signi®cantly altered at E1 or E2 but dramatically decreased at E3 ( Fig. 1 ; 100 and 90% decrease for SERCA2 and Na + /K + ATPase, respectively, P < 0.001 by ANOVA, Scheffe's post hoc test).
To ascertain that the changes in PMCA2 mRNA were also re¯ected at the protein level, we performed western blot analysis utilizing an antibody which previously has been reported to be speci®c for the PMCA isoform 2 (Stauffer et al., 1995) . Indeed, we did not detect any signal when crude membranes from kidney, a tissue which does not express PMCA2, were tested, indicating speci®city of the antibody (data not shown). In contrast, in spinal cord, one large band of mol. wt~135±140 kDa and another one of 130 kDa were visualized (Fig. 2) , in accordance with the 130, 135 and 138 kDa PMCA2 isoforms previously described (Stauffer et al., 1995) . The intensity of both bands decreased by 50% at E1, and by 80% at subsequent stages (Fig. 2) . The results by western analysis con®rm that the reduction in PMCA2 mRNA is accompanied by a decrease in protein level. Our ®ndings, taken together, raise the possibility of ion dyshomeostasis as one of the mechanisms leading to neural dysfunction or injury during EAE. The region selected for the design of primers and the predicted size for each RT±PCR product are presented. GenBank accession Nos are given in Table 1 .
PMCA2 expression is restricted to grey matter
To determine the cell type-speci®c expression and modulation of PMCA2, we performed in situ hybridization on lumbar spinal cord sections utilizing DIG-labelled riboprobes speci®c for this isoform. PMCA2 mRNA was localized exclusively to grey matter (Fig. 3A±D) . We did not detect any signal in white matter even when the substrate reaction was continued for 48 h. Many cells in the grey matter, including those in the ventral horn exhibiting motor neuron-like morphology, expressed PMCA2 ( Fig. 3C and D) . The exclusive expression of PMCA2 mRNA in spinal cord grey matter is consistent with the ®ndings of Stauffer et al. (1997) reporting PMCA2 immunoreactivity primarily associated with neurons in the brain.
In situ hydridization studies further con®rmed the results obtained by microarray analysis or RT±PCR, and indicated a Fig. 1 Modulation of ion pump expression during the clinical course of EAE as assessed by RT±PCR. RNA obtained from rats exhibiting tail weakness only (clinical score 1, E1), hindlimb weakness (clinical score 2, E2), hindlimb paralysis (clinical score 3, E3) and unaffected controls (C) was subjected to RT± PCR. Each lane shows the results obtained with pooled RNA with distinct groups of rats (2±3 rats/group). The expression of a-tubulin, a housekeeping gene not modulated in EAE, was utilized as control for experimental variations. PCRs for the various ion pumps and a-tubulin were performed in parallel utilizing the same reverse transcription mix for comparison. RNA subjected to PCR without reverse transcription con®rmed the lack of contaminating genomic DNA (negative control). PCR was performed for 35 cycles. The ®gure shows a representative gel and the graphs present the mean T SEM of three independent experiments (n = 5±6 with 2±3 rats per group, as indicated above). ***P < 0.001, signi®cantly different from control by ANOVA, Scheffe's post hoc test.
striking reduction in PMCA2 mRNA levels in EAE spinal cord ( Fig. 3E and F) when compared with controls. The magnitude of the change observed was variable in individual rats (n = 6). In some animals, PMCA2 expression was decreased dramatically to almost undetectable levels, as illustrated in Fig. 3 , whereas in others a less pronounced but clearly discernible diminution was observed.
To ensure that the decrease in PMCA2 expression was not due solely to a generic reduction in mRNA, we performed in situ hybridization utilizing DIG-labelled riboprobes for a-tubulin, a housekeeping gene not modulated during EAE. a-Tubulin expression in experimental samples was comparable with that of controls ( Fig. 3H and I ). Adjacent sections from control and experimental spinal cords were also stained with cresyl violet, which con®rmed the lack of extensive cell loss in grey matter (Fig. 3J and K) . To ascertain further that the decrease in PMCA2 mRNA levels was not due to grey matter cell death, we investigated the distribution of TUNELpositive cells in the spinal cord during EAE. TUNEL-positive cells were scarce in the grey matter even at clinical stage E3, did not exhibit neuronal morphology and localized mostly to white matter (results not shown). Taken together, these ®ndings indicate that cell death alone cannot account for the 88% decrease in PMCA2 mRNA levels at stages E1±E3, although its contribution at more advanced clinical phases cannot be ruled out. Thus, the reduction in PMCA2 mRNA levels during EAE may be attributed to decreased gene expression rather than loss of PMCA2-expressing cells, especially because it occurs at the earliest clinical times, before extensive neuronal death is evident (Smith et al., 2000) . It is noteworthy that at this stage of the disease, the in¯ammatory reaction in the lumbar spinal cord is quite extensive, as indicated by the distribution of ED-1-immunopositive activated microglia/macrophages in the grey and white matter (Fig. 3L±N ).
PMCA2 expression is modulated by kainic acid
Glutamate excitotoxicity has been implicated recently in EAE as a trigger that induces neuronal and oligodendrocyte loss and axonal injury (Pitt et al., 2000; Smith et al., 2000) . It has also been reported that kainic acid rapidly suppresses hippocampal PMCA expression, in vivo. Reductions in PMCA2 levels in the dentate gyrus were already observed 4 h following the administration of kainic acid, in vivo (Garcia et al., 1997) . Taken together, these ®ndings suggested that glutamate might be a possible modulator of PMCA2 expression in the spinal cord during EAE. To begin assessing this possibility, we exposed lumbar spinal cord slices to de®ned medium containing kainic acid (4±100 mM) or medium alone for 6 h at 37°C. Kainic acid (4 mM) decreased PMCA2 transcript levels by 86% as compared with controls ( Fig. 4A and B ; P < 0.001 by t test). Exposure to 20 or 100 mM kainic acid completely suppressed PMCA2 expression (not shown). In contrast, a-tubulin mRNA levels were unaltered, indicating speci®city in the changes observed (Fig. 4A) .
Previous reports have shown that prolonged exposure of neurons to kainic acid induces cell death, as indicated by DNA fragmentation and TUNEL immunoreactivity (Simonian et al., 1996; Cheung et al., 1998; Venero et al., 1999; Fujikawa et al., 2000; Giardina and Beart, 2001 ). Although our cultures were treated with kainic acid only for 6 h, we ascertained that the decrease in PMCA2 expression was not due to death of grey matter cells, by performing TUNEL assay on sections obtained from sister cultures maintained under the same experimental conditions. In controls, TUNEL-positive cells were infrequent (Fig. 4C) and were found only occasionally in the white matter and in the immediate vicinity of the dorsal root entry zone. Following exposure to kainate, TUNEL-positive cells were sparse in the ventral horn or intermediate zone grey matter, regions rich in PMCA2-expressing cells (Fig. 4D ), whereas they increased in the dorsal root entry zone and white matter (Fig. 4E) . We conclude that the decrease in PMCA2 mRNA levels in response to kainic acid is due to alterations in expression rather than to cell death.
Synaptic protein expression is decreased at onset of symptoms
cDNA microarray analysis also indicated changes in the expression of several neuronal proteins which mediate exocytosis. The most prominent decrease occurred in synapsin IIa, syntaxin 1B and SNAP-25 (synaptosomeassociated protein of 25 kDa) transcript levels, whereas the expression of Rab12, 14 and 16 was increased (Table 1) . Some members of the Rab family GTPases previously have Fig. 2 Modulation of PMCA2 and synapsin IIa protein levels at different phases of EAE (E1, E2, E3) and control (C) as assessed by western blot analysis. The ®gure shows a representative western blot. a-Tubulin was used as control for experimental variations. Quanti®cation of PMCA2 (135/138 and 130 kDa) band intensities revealed a 50% decrease at E1, and 80% at subsequent stages. As expected, a single band of 78 or 50 kDa was visualized with the synapsin IIa and a-tubulin antibodies, respectively. Quanti®cation of synapsin IIa band intensities indicated a 30, 60 and 80% decrease at E1, E2 and E3, respectively. The experiment was repeated twice and yielded similar results. been implicated in vesicular function (for a review see Geppert and Sudhof, 1998) , although the exact role of the aforementioned Rab isoforms has yet to be determined.
As synapsins, syntaxins and SNAP-25 are essential for vesicular function and neurotransmitter exocytosis, we further analysed the temporal pattern of their expression during the course of EAE. At E1, transcript levels of synapsin IIa and syntaxin 1B were decreased by 93 and 84%, respectively (P < 0.001 by ANOVA, Scheffe's post hoc test) and remained low thereafter (Fig. 5) . In addition, western blot analysis indicated 30, 60 and 80% reductions in synapsin IIa protein levels at E1, E2 and E3, respectively (Fig. 2) . SNAP-25 expression showed a tendency to decrease at E1 and E2, but the results were more variable and did not reach statistical signi®cance (Fig. 5) . By E3, however, SNAP-25 levels had decreased by 96% (P < 0.001 by ANOVA, Scheffe's post hoc test), in agreement with a recent study on chronic EAE in mice (Ibrahim et al., 2001) . In contrast to synapsins, syntaxin and SNAP-25, the transcript levels of Rab12, Rab14 and Rab16 were 2.9-, 4.3-and 2.6-fold increased, respectively ( Fig. 6 ; P < 0.001 for Rab12 and 14, and P < 0.01 for Rab16, by t test). These results raise the possibility of disturbances in neurotransmission at onset of EAE symptoms.
Increased cytochrome c oxidase expression suggests deregulation of mitochondrial metabolic activity at E2 cDNA microarray analysis indicated a strong increase in expression of cytochrome c oxidase subunits IV and Vb, suggesting altered mitochondrial metabolic activity (Table 1) . We corroborated this ®nding by RT±PCR and found that the most robust increases in cytochrome c oxidase IV and Vb subunit expression (~11-and 15-fold, respectively) occur at E2 and E3 (Fig. 7) . Mitochondrial dysfunction has often been associated with neuronal injury in CNS diseases and especially in response to intracellular Ca 2+ overload or oxidative stress (Fiskum, 2000; Hirai et al., 2001) . It is conceivable that changes in mitochondrial activity contribute to EAE pathology in a fashion similar to that observed in other CNS disorders such as ischaemia.
Reduced sodium channel expression occurs at advanced clinical phases
Sodium channels are critical mediators of impulse conduction along the axon. Therefore, the reduced expression of Na + channel b1 and 2 subunits and brain sodium channel II, as indicated by cDNA microarray analysis, was analysed further by RT±PCR. We found that the expression of all the aforementioned channels substantially decreased at E3 ( Fig. 8; 80±90% decrease) , con®rming the results obtained by microarray analysis. In contrast, no changes were observed at E1 and E2. Thus, potential abnormalities in Na + channel repertoires in nerve cells leading to impairment in impulse activity may contribute to the progression of symptoms at more advanced disease phases.
Discussion
The present study reports alterations in the expression of speci®c genes in the lumbar spinal cord during the clinical course of EAE, with special emphasis on the initial phase of symptomatic disease. In particular, we analysed the temporal expression pattern of genes which encode proteins playing critical roles primarily in neuronal function. Our results, taken together, indicate that changes in neuronal gene expression coincide with onset of symptoms. Thus, our ®ndings provide novel insights into the potential molecular mechanisms that may underlie the recently described neuronal dysfunction or injury during EAE (Ferguson et al., 1997; Trapp et al., 1998 Trapp et al., , 1999 De Stefano et al., 1999; Bitsch et al., 2000; Smith et al., 2000; Bjartmar and Trapp, 2001; Bjartmar et al., 2001; Peterson et al., 2001) . We propose that ion dyshomeostasis due to aberrant Ca 2+ extrusion and abnormal neurotransmitter release resulting from anomalies in the expression of vesicular proteins may promote the onset of neural de®cits. As the disease progresses, perturbed mitochondrial function and reduced impulse conduction due to decreases in Na + channel expression may exacerbate clinical symptoms.
Glutamate-mediated changes in PMCA2 expression may induce neuronal dysfunction at onset of EAE symptoms Increases in intracellular Ca 2+ often have been associated with cell dysfunction, injury and death in many pathological conditions of the CNS, including ischaemia, Alzheimer's and Parkinson's disease (for reviews see Paschen, 2000; O'Neill et al., 2001; Paschen and Frandsen, 2001 ). Yet, the contribution of Ca 2+ dyshomeostasis to EAE and the affected mechanisms have not been de®ned. A loss in Ca 2+ balance may result from defects in mechanisms that regulate Ca 2+ entry, extrusion or intracellular sequestration. A role for voltage-dependent channel-mediated Ca 2+ in¯ux in axonal and neuronal degeneration during multiple sclerosis and EAE has been reported (Kornek et al., 2000 (Kornek et al., , 2001 . To our knowledge, our study is the ®rst report implicating a pivotal role for distinct ion pumps involved in calcium extrusion and sequestration in EAE pathogenesis.
Whereas PMCAs are major pumps modulating Ca 2+ extrusion, SERCA isoforms play critical roles in sequestration of Ca 2+ into the endoplasmic reticulum. Our results indicate a profound decrease in PMCA2 expression at the earliest manifestation of symptoms, which is then followed by a signi®cant reduction in SERCA2 transcript levels at subsequent clinical phases. Such temporal changes in ion pump expression may promote accumulation of Ca 2+ in the cytoplasm, increasing the vulnerability of neurons to cal-cium-mediated injury. This may be one possible candidate mechanism underlying neuronal decline, and implicates PMCA2 and SERCA2 as potential targets for therapeutic interventions. Importantly, our results may be relevant to the human disease, as a recent study found a decrease in PMCA2 trancript levels by microarray analysis of three multiple sclerosis brains (Lock et al, 2002, online supplementary table B) .
The PMCA gene family encodes four isoforms which initially were considered to be necessary only for the maintenance of basal Ca 2+ levels. However, emerging evidence indicates that they may play important roles in pathological conditions (Garcia and Strehler, 1999) especially after overstimulation of glutamate receptors which causes intracellular Ca 2+ overload (Choi, 1992; Mody and MacDonald, 1995) . PMCA2 is expressed primarily in brain and heart, in a region-and cell-type speci®c manner (Garcia and Strehler, 1999) . The highly restricted tissue distribution of PMCA2 suggests that this isoform plays unique, specialized and non-redundant roles in the CNS. Indeed, PMCA2-null mice exhibit deafness, and unsteady gait and balance, indicating that the presence of other isoforms does not compensate for the absence of PMCA2 (Kozel et al., 1998) .
The triggers that induce changes in the expression of Ca 2+ pumps during EAE have not been de®ned. Glutamate is an appealing candidate because of its well-known effects on Ca 2+ homeostasis (Choi, 1992) and because of the recently reported contribution of excitotoxicity to EAE pathogenesis (Pitt et al., 2000; Smith et al., 2000) . Administration of AMPA/kainate antagonists ameliorates EAE symptoms in mice and rats, and prevents neuronal and oligodendrocyte loss and axonal damage. Moreover, kainate-induced decreases in PMCA1 and PMCA2 expression in hippocampal pyramidal cells are followed by neuronal death, in vivo (Garcia et al., 1997) . These ®ndings raise the possibility of kainate receptor-mediated alterations in PMCA2 expression in the spinal cord during EAE. In fact, we found that exposure of spinal cord slice cultures to relatively low concentrations of kainate (4 mM) for 6 h dramatically decreased PMCA2 transcript levels. Thus, even low glutamate levels may be suf®cient to affect PMCA2 expression when cells are exposed to the neurotransmitter continuously. We propose that, at onset of EAE, persistent stimulation of kainate receptors following moderate but sustained elevations in glutamate concentrations may lead to downregulation of Ca 2+ pump expression, promote Ca 2+ overload and initiate the previously described injury cascade (Shields et al., 1998) . PCR analysis. C = control, i.e. slices maintained only in de®ned medium and vehicle; KA = slices maintained in medium containing 4 mM kainic acid; (PMCA2) negative control, i.e. RNA subjected to PCR without reverse transcription to ascertain the lack of contaminating genomic DNA. The graph in B shows the densitometric quanti®cation of the bands in the gel and re¯ects the mean T SEM of three independent experiments (n = 6, ***P < 0.001 by t test). To rule out the possibility that the decrease in PMCA2 expression was due to cell death, slices in sister cultures were sectioned for assessment of TUNEL-positive cells. (C and D) Photomicrographs of a representative region in the ventral horn in controls and kainic acid-treated slices, respectively. Note that TUNEL-positive cells are absent in controls (C) and very few in experimental samples (D, arrows). In kainic acid-treated sections, small, TUNELpositive cells were con®ned primarily to the edge of the dorsal root entry zone (E, arrows). Scale bar = 100 mm.
Aberrant neurotransmitter exocytosis may affect neuronal communication during the early course of the disease
In addition to PMCA2, the expression of synapsin IIa and syntaxin 1B, vesicular proteins that are crucial for exocytosis in presynaptic terminals, was decreased dramatically at onset of clinical symptoms. Synapsins are a family of synaptic vesicle-associated phosphoproteins that are required for the tethering of vesicles to each other and to cytoskeletal proteins such as actin. Phosphorylation of synapsins liberates vesicles from the cytoskeleton, enabling their traf®cking in the presynaptic terminal. Synapsins are essential for the formation, maintenance and regulation of the reserve synaptic pool in the vicinity of the active zone. Decreases in synapsin The expression of a-tubulin, a housekeeping gene not modulated in EAE, was utilized as control for experimental variations. PCRs for the various vesicular proteins and a-tubulin were performed in parallel utilizing the same reverse transcription mix. RNA subjected to PCR without reverse transcription ascertained the lack of contaminating genomic DNA (not shown). PCR was performed for 35 cycles. The ®gure shows representative gels, and graphs present the mean T SEM of three independent experiments (n = 5±6 with 2±3 rats per group, as indicated above). ***P < 0.001, signi®cantly different from control by ANOVA, Scheffe's post hoc test. expression reduce the number of synaptic vesicles distal to the active zone, leading to synaptic fatigue (Pieribone et al., 1995; Rosahl et al., 1995) . Moreover, perturbations in synapsin function inhibit or slow down neurotransmitter release.
Syntaxins belong to a class of proteins called SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) hypothesized to be essential for the docking and fusion of synaptic vesicles. Vesicle-associated SNAREs, such as synaptobrevin, and target membrane-associated SNAREs, such as syntaxins and SNAP-25, form a high af®nity complex. Formation of the SNARE complex draws vesicles to the target membrane and induces membrane fusion. In our experimental paradigm, we observed a decrease in both syntaxin 1B and SNAP-25. However, the dramatic reduction in syntaxin 1B occurred at onset of symptoms, whereas SNAP-25 showed a tendency to decrease, which was statistically signi®cant only at a later clinical stage (E3). Hence, changes in the expression of some synapsin and SNARE proteins can interfere with normal neuronal communication during EAE.
The notion of synapse pathology is suggested further by changes observed in Rab12, 14 and 16 expression. Rab isoforms belong to the Ras superfamily of small GTP-binding proteins, and have been implicated in the attachment of vesicles to target membranes. A member of this family, Rab3, is localized to synaptic vesicles and limits the amount of neurotransmitter released in response to Ca 2+ signal. However, a similar function for Rab12, 14 and 16 has not yet been de®ned. Rab12 and 14 are also expressed in oligodendrocytes and may play additional roles (Burcelin et al., 1997) . Therefore, the exact contribution of the aforementioned Rab isoforms to EAE pathogenesis remains to be determined.
Perturbations in mitochondrial function may contribute to cellular injury at advanced EAE stages Cellular injury often has been associated with disturbances in mitochondrial function. Interestingly, our microarray analysis indicated a pronounced increase in the expression of mitochondrial cytochrome c oxidase subunits IV and Vb, a ®nding which was validated further by RT±PCR. Cytochrome c oxidase has been used frequently as a marker for neuronal metabolic activity, especially in pathological conditions involving oxidative stress. Neurons subject to oxidative Fig. 6 Modulation of Rab isoform expression during EAE as assessed by RT±PCR. Each lane represents results obtained with distinct groups of control and EAE rats in three independent experiments (2±3 rats/ group). The graphs show the mean T SEM of the densitometric quanti®cation of bands (n = 3). ***P < 0.001 and **P < 0.01, signi®cantly different from control by t test. damage show abnormalities in mitochondrial dynamics even in the absence of any apparent indication of degeneration Smith et al., 1997) . Elevations in cytochrome c oxidase expression or function in vulnerable neuronal subpopulations in Alzheimer's disease, following traumatic brain injury and preceding apoptotic death of spinal cord motor neurons after sciatic nerve avulsion, have been reported (Martin et al., 1999; Harris et al., 2001; Hirai et al., 2001) . Thus, an increase in cytochrome c oxidase expression may re¯ect aberrant energy metabolism and oxidative damage in the spinal cord during EAE.
Alterations in sodium channel expression may exacerbate symptoms by affecting impulse conduction Neurological symptoms in multiple sclerosis and EAE models associated with extensive myelin loss have been attributed largely to a failure in impulse conduction in demyelinated axons. However, our results indicating a dramatic decrease in the expression of important Na + channels at advanced EAE stages (E3) suggest that impaired nerve conduction may also be due to alterations in Na + channel levels. Indeed, the expression and function of various other sodium channels are affected after nerve injury, in¯ammation and demyelination (Dib-Hajj et al., 1996; Cummins and Waxman, 1997; Schild et al., 1997; Gould et al., 1998; Black et al., 2000) . A change in the expression of sensory neuron-speci®c sodium channels in Purkinje cells during EAE has been reported (Black et al., 2000) .
In conclusion, our results suggest that the onset of EAE symptoms may be due partially to disruption of neuronal function and communication as a consequence of changes in mechanisms regulating calcium extrusion and neurotransmitter exocytosis. Exacerbation of symptoms at later stages may result from abnormalities in additional processes including impulse conduction and energy metabolism. Future studies will determine the role of the differentially expressed genes in the onset and progression of EAE and their precise contribution to neuronal dysfunction during the different stages of the disease. 
